Mirum Pharmaceuticals, Inc.: cashflow_investing
| Value | {"amount": -24960000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-09-30 |
| Status | current |
| Entity | Mirum Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:53:37.700410+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/56ef9b33-57a5-4f07-8fdd-baadc69cf6b1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001759425-25-000054Retrieved: 2026-08-19T17:53:37.700410+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001759425/cashflow-investing/2025-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/56ef9b33-57a5-4f07-8fdd-baadc69cf6b1
History
- no predecessors — first report